Prognostic association between d-dimer thresholds and 30-day pulmonary embolism diagnosis among emergency department patients with suspected SARS-CoV-2 infection: a Canadian COVID-19 Emergency Department Rapid Response Network study

[1]  J. Kasprzak,et al.  Age-Adjusted D-Dimer Levels May Improve Diagnostic Assessment for Pulmonary Embolism in COVID-19 Patients , 2022, Journal of clinical medicine.

[2]  L. Morrison,et al.  The CCEDRRN COVID-19 Mortality Score to predict death among nonpalliative patients with COVID-19 presenting to emergency departments: a derivation and validation study , 2022, CMAJ open.

[3]  L. Morrison,et al.  CCEDRRN COVID-19 Infection Score (CCIS): development and validation in a Canadian cohort of a clinical risk score to predict SARS-CoV-2 infection in patients presenting to the emergency department with suspected COVID-19 , 2021, BMJ Open.

[4]  R. Rosychuk,et al.  Diagnostic Yield of Screening for SARS-CoV-2 among Patients Admitted for Alternate Diagnoses , 2021, medRxiv.

[5]  B. Aryal,et al.  D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19 , 2021, PloS one.

[6]  Jennifer L. White,et al.  The impact of COVID‐19 on the sensitivity of D‐dimer for pulmonary embolism , 2021, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[7]  M. Taljaard,et al.  Decision support for computed tomography in the emergency department: a multicenter cluster-randomized controlled trial , 2021, Canadian Journal of Emergency Medicine.

[8]  P. Meyer,et al.  V/Q SPECT/CT in the Time of COVID-19: Changing the Order to Improve Safety Without Sacrificing Accuracy , 2021, Journal of Nuclear Medicine.

[9]  K. Syrigos,et al.  Venous thromboembolism in COVID-19: A systematic review and meta-analysis , 2021, Vascular medicine.

[10]  L. Morrison,et al.  Development of the Canadian COVID-19 Emergency Department Rapid Response Network population-based registry: a methodology study , 2021, CMAJ Open.

[11]  B. Clary,et al.  Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis , 2020, EClinicalMedicine.

[12]  H. Mansouritorghabeh,et al.  D-dimer level in COVID-19 infection: a systematic review , 2020, Expert review of hematology.

[13]  W. Ge,et al.  Incidence of Venous Thromboembolism in Hospitalized Coronavirus Disease 2019 Patients: A Systematic Review and Meta-Analysis , 2020, Frontiers in Cardiovascular Medicine.

[14]  C. Helissey,et al.  Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department , 2020, European Radiology.

[15]  Q. Fan,et al.  D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19 , 2020, Journal of Thrombosis and Haemostasis.

[16]  L. Beenen,et al.  Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study , 2017, The Lancet.

[17]  Andrew McRae,et al.  Limitations of pulmonary embolism ICD-10 codes in emergency department administrative data: let the buyer beware , 2017, BMC Medical Research Methodology.

[18]  David Moher,et al.  STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies , 2015, BMJ : British Medical Journal.

[19]  O. Rutschmann,et al.  Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. , 2014, JAMA.

[20]  G. Kovacs,et al.  Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and d-dimer , 2001, Annals of Internal Medicine.